Everolimus and Basiliximab Permit Suppression by Human CD4+CD25+ Cells in vitro
Open Access
- 11 February 2005
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 5 (3) , 454-464
- https://doi.org/10.1111/j.1600-6143.2005.00758.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- HLA-DR Matching and Immune RegulationAmerican Journal of Transplantation, 2004
- Effects of CD25 monoclonal antibody on proliferative and effector functions of alloactivated human T cellsin vitroEuropean Journal of Immunology, 2004
- Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery1Transplantation, 2004
- Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activationEuropean Journal of Immunology, 2003
- Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivoBlood, 2003
- Dominant transplantation tolerance impairs CD8+ T cell function but not expansionNature Immunology, 2002
- Transcriptional Mechanisms Underlying Lymphocyte ToleranceCell, 2002
- SIROLIMUS (RAPAMYCIN)-BASED THERAPY IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1999
- PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY USED IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1995
- SPARING OF SUPPRESSOR CELLSTransplantation, 1984